MedWatch Needs Space To Note Consumers’ OK To Contact Doctors – CRN
This article was originally published in The Tan Sheet
FDA should revise its estimate of the time dietary supplement firms will need to report serious adverse events because the burden will be higher than the agency's estimate of no time, the Council for Responsible Nutrition says
You may also be interested in...
Substantive changes to FDA's MedWatch forms could come from the agency's MedWatch Plus program as soon as later this year
FDA's recommendation for complete addresses on OTC and dietary supplement product labels in order to comply with the adverse event reporting law exceeds not only Congress's intent, but also the requirements for all other products regulated by the agency, industry groups say
Training potential reporters of adverse events may be crucial to the effectiveness of a mandatory adverse event reporting system, industry stakeholders say